Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mengxia Yu

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
BMC Psychology|June 30, 2026
Development and validation of the subjective financial distress scale for cancer patientsTianying Yao, Linglong Liu, Xiaoxuan Li, et al.
Ebiomedicine|February 7, 2018
High Expression of TET1 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia From Two CohortsJinghan Wang, Fenglin Li, Zhixin Ma, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 24, 2014
[Clinical significance of TET2 gene expression in 157 adult acute myeloid leukemia patients with normal cytogenetics]Zhijuan Zhu, Jian Chen, Mengxia Yu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 3, 2015
[The clinical efficacy of all-trans retinoic acid plus arsenic trioxide in 177 newly diagnosed acute promyelocytic leukemia patients]Ying Lu, Fenglin Li, Qitian Mu, et al.
Oncotarget|November 26, 2019
Correction: The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemiaXia Li, Xiufeng Yin, Huafeng Wang, et al.
NPJ Digital Medicine|February 15, 2025
Smartphone administered pulsed radio frequency energy therapy for expedited cutaneous wound healingMengxia Yu, Hongjia Yang, Haoteng Ye, et al.
Oncotarget|January 7, 2017
The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemiaXia Li, Xiufeng Yin, Huafeng Wang, et al.
Scientific Reports|June 8, 2017
PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulationChao Hu, Mengxia Yu, Yanling Ren, et al.
Npj Flexible Electronics|December 6, 2024
Digitally-defined ultrathin transparent wireless sensor network for room-scale imperceptible ambient intelligenceYunxia Jin, Mengxia Yu, Dat T Nguyen, et al.
Scientific Reports|November 9, 2017
Publisher Correction: PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulationChao Hu, Mengxia Yu, Yanling Ren, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
BMC Psychology|June 30, 2026
Development and validation of the subjective financial distress scale for cancer patientsTianying Yao, Linglong Liu, Xiaoxuan Li, et al.
Ebiomedicine|February 7, 2018
High Expression of TET1 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia From Two CohortsJinghan Wang, Fenglin Li, Zhixin Ma, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 24, 2014
[Clinical significance of TET2 gene expression in 157 adult acute myeloid leukemia patients with normal cytogenetics]Zhijuan Zhu, Jian Chen, Mengxia Yu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 3, 2015
[The clinical efficacy of all-trans retinoic acid plus arsenic trioxide in 177 newly diagnosed acute promyelocytic leukemia patients]Ying Lu, Fenglin Li, Qitian Mu, et al.
Oncotarget|November 26, 2019
Correction: The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemiaXia Li, Xiufeng Yin, Huafeng Wang, et al.
NPJ Digital Medicine|February 15, 2025
Smartphone administered pulsed radio frequency energy therapy for expedited cutaneous wound healingMengxia Yu, Hongjia Yang, Haoteng Ye, et al.
Oncotarget|January 7, 2017
The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemiaXia Li, Xiufeng Yin, Huafeng Wang, et al.
Scientific Reports|June 8, 2017
PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulationChao Hu, Mengxia Yu, Yanling Ren, et al.
Npj Flexible Electronics|December 6, 2024
Digitally-defined ultrathin transparent wireless sensor network for room-scale imperceptible ambient intelligenceYunxia Jin, Mengxia Yu, Dat T Nguyen, et al.
Scientific Reports|November 9, 2017
Publisher Correction: PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulationChao Hu, Mengxia Yu, Yanling Ren, et al.
Pageof 7